Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Edwin Robbins

Physician Assistant Lexington, KY Physician Assistant

NPI 1629184593 CMS profile 10565868

120 N Eagle Creek, Lexington, KY 40509

Open in the dashboard

General payments

$9,890

344 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Edwin Robbins of Lexington, KY is reported in the CMS Open Payments database as having received $9,890 across 344 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $139 3
2024 General $5,227 85
2023 General $1,295 69
2022 General $1,604 85
2021 General $1,626 102

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edwin Robbins
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Edwin Robbins were reported at $139. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Edwin Robbins Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,626 $132 $37–$438 $132
2022 $1,604 $155 $48–$522 $149
2023 $1,295 $167 $52–$557 $160
2024 $5,227 $178 $55–$600 $164
2025 $139 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Salix Pharmaceuticals, a division of Bausch Health US, LLC $5,819 137 payments
  2. Collegium Pharmaceutical, Inc. $759 44 payments
  3. Nevro Corp. $443 8 payments
  4. Scilex Pharmaceuticals Inc. $327 19 payments
  5. Protega Pharmaceutials LLC $312 6 payments
  6. RedHill Biopharma Inc. $199 14 payments
  7. Teva Pharmaceuticals USA, Inc. $192 13 payments
  8. AbbVie, Inc. $173 12 payments
  9. Arbor Pharmaceuticals, Inc. $162 11 payments
  10. Amgen Inc. $155 8 payments
  11. Other $1,349 72 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,276 338 payments
  2. Consulting Fee $2,000 1 payment
  3. Travel and Lodging $1,314 4 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $300 1 payment
Products named General payments · program years 2021–2025
  1. XIFAXAN $7,413 20 payments
  2. RELISTOR Gastroenterology $4,006 11 payments
  3. TRULANCE $3,706 10 payments
  4. RELISTOR Gastroenterology $1,813 126 payments
  5. XTAMPZA $587 36 payments
  6. Omnia $300 5 payments
  7. ZTLido $272 16 payments
  8. Roxybond $227 4 payments
  9. Movantik $199 14 payments
  10. AIMOVIG $197 10 payments
  11. Other $2,465 133 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 4 billing codes

Paid by Medicare

$65,672

Medicare's payments for the services billed

Medicare patients

560

Average age 68

Services billed

1,248

340 women, 220 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 43%
Diabetes 39%
Ischemic heart disease 31%
COPD 30%
Chronic kidney disease 25%
Heart failure 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 12 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XIFAXAN
  • Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,853
$1,853 — —
RELISTOR
  • Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,763
$1,763 — —
TRULANCE
  • Salix Pharmaceuticals, a division of Bausch Health US, LLC $927
$927 — —
XTAMPZA
  • Collegium Pharmaceutical, Inc. $176
$176 — —
ZTLido
  • Scilex Pharmaceuticals Inc. $97
$97 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 12 in the dashboard with a free account

Records

344 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record